Whole-exome sequencing reveals genetic underpinnings of salivary adenoid cystic carcinoma in the Chinese population

Shuhang Wang; Yue Yu; Yuan Fang; Huiyao Huang; Dawei Wu; Hong Fang; Ying Bai; Chao Sun; Anqi Yu; Qi Fan; Zicheng Yu; Chao Zhang; Changxi Wang; Zaixian Tai; Yi Huang; Ning Li

doi:10.1016/j.jgg.2020.07.001

Volume 47 Issue 7

Jul. 2020

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2020 > 47(7): 397-401

PDF( 1044 KB)

Whole-exome sequencing reveals genetic underpinnings of salivary adenoid cystic carcinoma in the Chinese population

doi: 10.1016/j.jgg.2020.07.001

1
Department of Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
2
Geneplus-Shenzhen, Shenzhen, 518000, China
3
Department of Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China

More Information

Corresponding author: E-mail address: ncctrials@cicams.ac.cn (Ning Li)
Publish Date: 2020-07-25

Abstract

These authors contributed equally to this work.

FullText(HTML)

References(22)

References

[1]	Agrawal, N., Frederick, M.J., Pickering, C.R., Bettegowda, C., Chang, K., Li, R.J., Fakhry, C., Xie, T.X., Zhang, J., Wang, J., Zhang, N., El-Naggar, A.K., Jasser, S.A., Weinstein, J.N., Trevino, L., Drummond, J.A., Muzny, D.M., Wu, Y., Wood, L.D., Hruban, R.H., Westra, W.H., Koch, W.M., Califano, J.A., Gibbs, R.A., Sidransky, D., Vogelstein, B., Velculescu, V.E., Papadopoulos, N., Wheeler, D.A., Kinzler, K.W., Myers, J.N., 2011. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154-1157.
[2]	Camos, M., Esteve, J., Jares, P., Colomer, D., Rozman, M., Villamor, N., Costa, D., Carrio, A., Nomdedeu, J., Montserrat, E., Campo, E., 2006. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression. Cancer Res. 66, 6947-6954.
[3]	Chaturvedi, A.K., Engels, E.A., Anderson, W.F., Gillison, M.L., 2008. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 26, 612-619.
[4]	Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X.Q., He, J., 2016. Cancer statistics in China, 2015. CA Cancer J. Clin. 66, 115-132.
[5]	Cuiffo, B.G., Karnoub, A.E., 2016. Silencing FOXP2 in breast cancer cells promotes cancer stem cell traits and metastasis. Mol. Cell Oncol. 3, e1019022.
[6]	Fang, J.Y., Richardson, B.C., 2005. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 6, 322-327.
[7]	Gatta, G., Capocaccia, R., Trama, A., Martinez-Garcia, C., Group, R.W., 2010. The burden of rare cancers in Europe. Adv. Exp. Med. Biol. 686, 285-303.
[8]	Gronbaek, K., Hother, C., Jones, P.A., 2007. Epigenetic changes in cancer. APMIS 115, 1039-1059.
[9]	Ho, A.S., Kannan, K., Roy, D.M., Morris, L.G., Ganly, I., Katabi, N., Ramaswami, D., Walsh, L.A., Eng, S., Huse, J.T., Zhang, J., Dolgalev, I., Huberman, K., Heguy, A., Viale, A., Drobnjak, M., Leversha, M.A., Rice, C.E., Singh, B., Iyer, N.G., Leemans, C.R., Bloemena, E., Ferris, R.L., Seethala, R.R., Gross, B.E., Liang, Y., Sinha, R., Peng, L., Raphael, B.J., Turcan, S., Gong, Y., Schultz, N., Kim, S., Chiosea, S., Shah, J.P., Sander, C., Lee, W., Chan, T.A., 2013. The mutational landscape of adenoid cystic carcinoma. Nat. Genet. 45, 791-798.
[10]	Kiyoshima, T., Shima, K., Kobayashi, I., Matsuo, K., Okamura, K., Komatsu, S., Rasul, A.M., Sakai, H., 2001. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol. 37, 315-322.
[11]	Liu, J., Shao, C., Tan, M.L., Mu, D., Ferris, R.L., Ha, P.K., 2012. Molecular biology of adenoid cystic carcinoma. Head Neck 34, 1665-1677.
[12]	Lyu, H.X., Wang, Z.R., Gao, Y.Q., Yu, M., Li, B.Q., Zhang, Z.B., 2019. Clinical pathologic analysis on 3 724 cases of salivary gland tumors. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chin. J Stomatol. 54, 10-16.
[13]	Matsuba, H.M., Simpson, J.R., Mauney, M., Thawley, S.E., 1986a. Adenoid cystic salivary gland carcinoma: a clinicopathologic correlation. Head Neck Surg. 8, 200-204.
[14]	Matsuba, H.M., Spector, G.J., Thawley, S.E., Simpson, J.R., Mauney, M., Pikul, F.J., 1986b. Adenoid cystic salivary gland carcinoma. A histopathologic review of treatment failure patterns. Cancer 57, 519-524.
[15]	Mitani, Y., Li, J., Rao, P.H., Zhao, Y.J., Bell, D., Lippman, S.M., Weber, R.S., Caulin, C., El-Naggar, A.K., 2010. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance. Clin. Cancer Res. 16, 4722-4731.
[16]	Ramsay, R.G., Gonda, T.J., 2008. MYB function in normal and cancer cells. Nat. Rev. Cancer 8, 523-534.
[17]	Rettig, E.M., Talbot, C.C., Jr, Sausen, M., Jones, S., Bishop, J.A., Wood, L.D., Tokheim, C., Niknafs, N., Karchin, R., Fertig, E.J., Wheelan, S.J., Marchionni, L., Considine, M., Ling, S., Fakhry, C., Papadopoulos, N., Kinzler, K.W., Vogelstein, B., Ha, P.K., Agrawal, N., 2016. Whole-genome sequencing of salivary gland adenoid cystic carcinoma. Canc. Prev. Res. (Phila) 9, 265-274.
[18]	Semenova, E.A., Kwon, M.C., Monkhorst, K., Song, J.Y., Bhaskaran, R., Krijgsman, O., Kuilman, T., Peters, D., Buikhuisen, W.A., Smit, E.F., Pritchard, C., Cozijnsen, M., van der Vliet, J., Zevenhoven, J., Lambooij, J.P., Proost, N., van Montfort, E., Velds, A., Huijbers, I.J., Berns, A., 2016. Transcription factor NFIB is a driver of small cell lung cancer progression in mice and marks metastatic Disease in patients. Cell Rep. 16, 631-643.
[19]	Stephens, P.J., Davies, H.R., Mitani, Y., Van Loo, P., Shlien, A., Tarpey, P.S., Papaemmanuil, E., Cheverton, A., Bignell, G.R., Butler, A.P., Gamble, J., Gamble, S., Hardy, C., Hinton, J., Jia, M., Jayakumar, A., Jones, D., Latimer, C., McLaren, S., McBride, D.J., Menzies, A., Mudie, L., Maddison, M., Raine, K., Nik-Zainal, S., O'Meara, S., Teague, J.W., Varela, I., Wedge, D.C., Whitmore, I., Lippman, S.M., McDermott, U., Stratton, M.R., Campbell, P.J., El-Naggar, A.K., Futreal, P.A., 2013. Whole exome sequencing of adenoid cystic carcinoma. J. Clin. Invest. 123, 2965-2968.
[20]	Sumimoto, H., Imabayashi, F., Iwata, T., Kawakami, Y., 2006. The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J. Exp. Med. 203, 1651-1656.
[21]	Suva, M.L., Riggi, N., Bernstein, B.E., 2013. Epigenetic reprogramming in cancer. Science 339, 1567-1570.
[22]	Theriault, C., Pinard, M., Comamala, M., Migneault, M., Beaudin, J., Matte, I., Boivin, M., Piche, A., Rancourt, C., 2011. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol. Oncol. 121, 434-443.